Skip to main content
News Icon

News categories: Honors & Funding

University of Bonn and ImmunoSensation² receive Henriette Herz-Price

Concept for attracting young international talent awarded

As one of eight universities in Germany, the University of Bonn was being awarded the Henriette Herz Prize by the Alexander von Humboldt Foundation. The university receives 125,000 euros for its concept for attracting internationally highly qualified young researchers.

"For years, attracting top international talent has also been more and more important in the university environment", explains Prof. Dr. Dr. h.c. Michael Hoch, the rector of the University of Bonn. "In the competition for the best talent, it is therefore essential to make our outstanding location advantages visible and to set the threshold for a location change as low as possible. We are very happy about this great success, thanks to which we can now implement this pilot project. "

With a bundle of various measures, international talents will be introduced to the work at the University of Bonn and in particular in the ImmunoSensation Cluster of Excellence. Talented women are also to be addressed in a targeted manner.

With virtual 360 ° campus tours and interactive laboratory visits, researchers can also get to know the excellence location from abroad. A digital roadshow with subsequent career fairs is intended to promote exchange and make it easier to make a decision to work at the University of Bonn. "These digital formats can only ever be the first step," explains Tina Odenthal from the International Office. "It was therefore important for us to include travel grants so that the young talents and their families can come straight to Bonn for one to two weeks. We want to achieve an intensive exchange with the researchers and a removal of possible hurdles for a change. " The pilot project is of great importance for the ImmunoSensation Cluster of Excellence. "For us as a cluster of excellence, recruiting top international talent is a particular concern," emphasizes Dr. Catherine Drescher from ImmunoSensation. "With this recruitment concept, we aim at a targeted exchange with talents and a knowledge transfer that is enriching for all parties."

Related news

Gruppenbild Preistrager Lisec Artz Preisverleihung

News categories: Honors & Funding

Niklas Klümper and Varun Venkataramani receive Lisec-Artz Prize

Dr. Varun Venkataramani of the Faculty of Medicine at Heidelberg University and ImmunoSensation² member Dr. Niklas Klümper of the University Hospital Bonn have been awarded the Lisec Artz Prize for their outstanding cancer research. The University of Bonn Foundation and the University of Bonn Faculty of Medicine presented the awards to the two researchers on Tuesday, November 18, 2025 at the University Hospital Bonn (UKB) as part of the Cluster Science Days event held by the ImmunoSensation² Cluster of Excellence. The prize is worth a total of 15,000 euros.
View entry
20251103 PM Prof Wihelm

News categories: Honors & Funding

Prof. Christoph Wilhelm receives €1.25 million DFG funding for Reinhart-Koselleck project

The German Research Foundation (DFG) is funding a Reinhart-Koselleck project at the University Hospital Bonn (UKB) within the Cluster of Excellence ImmunoSensation² at the University of Bonn with €1.25 million. The research team led by Prof. Christoph Wilhelm, Chair of Immunopathology at the Institute of Clinical Chemistry and Clinical Pharmacology, aims to investigate how the body maintains the balance of the gut microbiome during periods of illness and food scarcity.
View entry
Aschenbrenner_Anna_Award_22102025

News categories: Honors & Funding

Tobias-Welte Prize for Anna Aschenbrenner

Dr. Anna Aschenbrenner, a researcher at the German Center for Neurodegenerative Diseases (DZNE) in Bonn, has received the Tobias-Welte Prize from the German Sepsis Society, endowed with 3,000 Euros. She was honored for her pioneering work published in Cell, in which she and her team uncovered the molecular mechanisms underlying the life-saving effects of dexamethasone in severe COVID-19.
View entry

Back to the news overview